Anavex Life Sciences
AVXL
#7366
Rank
NZ$0.71 B
Marketcap
NZ$7.75
Share price
-3.40%
Change (1 day)
-50.92%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -NZ$80.65 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$87.85 Million a decrease over its 2023 earnings that were of -NZ$76.54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$80.65 Million-8.19%
2024 -NZ$87.85 Million14.77%
2023 -NZ$76.54 Million-17.49%
2022 -NZ$92.77 Million22.96%
2021 -NZ$75.44 Million35.36%
2020 -NZ$55.74 Million12.65%
2019 -NZ$49.48 Million29.09%
2018 -NZ$38.33 Million36.33%
2017 -NZ$28.12 Million17.11%
2016 -NZ$24.01 Million20.91%
2015 -NZ$19.86 Million-6.29%
2014 -NZ$21.19 Million337.28%
2013 -NZ$4.85 Million
2008 -NZ$8.97 Million106.01%
2007 -NZ$4.35 Million8848.98%
2006 -NZ$0.05 Million-79.99%
2005 -NZ$0.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$0.11 B-242.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$0.11 B-240.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$8.18 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$11.28 Million-85.86%๐Ÿ‡บ๐Ÿ‡ธ USA